Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Coinbase Global, Inc. (COIN) vs Nuwellis Inc (NUWE) Price & Performance

Coinbase Global, Inc.Trade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Coinbase Global, Inc. vs Nuwellis Inc — how do they compare? Coinbase Global, Inc. trades at $175.66 (market cap $47.08B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Coinbase Global, Inc. is far larger — about 21400× Nuwellis Inc's market cap, and Coinbase Global, Inc. is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Coinbase Global, Inc. for 78 Days and Nuwellis Inc for 26 Days on average.

COINNUWE
Market Cap
$47.08B$2.20M
Volume
7,082,928121,544
Sector
FinancialsHealth
52-Week High
$387.00$146.65
52-Week Low
$141.09$0.68
Typical Hold Time
78 Days26 Days
Enterprise Value
$44.73B-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Coinbase Global, Inc.

COIN trades at $178.45, down 3.92% with bearish technical signals. The stock shows mixed fundamentals with strong revenue growth to $7.18B in 2025 but negative net income margin of -15.72% and recent earnings misses. Analyst consensus remains positive with 55% buy ratings and $211.55 price target, while technical indicators show support at $177 and resistance at $180.

Outlook remains cautiously optimistic given analyst support and recent CFTC approval for derivatives expansion, but risks include volatile earnings performance, high valuation multiples, and regulatory uncertainty. The stock's current price near support levels presents potential entry point for long-term investors despite near-term headwinds.

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

COIN
76% Buy24% Sell
Avg holding period · 78 Days
NUWE
40% Buy60% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About Coinbase Global, Inc.

Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.

Read more on COIN →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →